Dianthus Therapeutics, Inc. /DE/

UBS Group AG DNTH
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
781,282
Value ($000)
65,565
Weight
0.0%
2023 Q3 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).